RACQUEL VENAFRA: Open Payments
NPI 1356881601 · EXTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$777 in 35 payments from 12 companies in 2025. Trend: 2023 $1,221 · 2024 $1,163 · 2025 $777
Food & beverage: $674Education: $103
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $226 |
| Galderma Laboratories, L.P. | 5 | $187 |
| Organon LLC | 8 | $77 |
| ABBVIE INC. | 3 | $67 |
| Amgen Inc. | 3 | $51 |
| LEO Pharma Inc. | 2 | $38 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $36 |
| UCB, Inc. | 1 | $24 |
| ConvaTec Inc. | 1 | $23 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $19 |
Products named: TREMFYA, NEMLUVIO, SKYRIZI, Otezla, ADBRY, Bimzelx, INNOVAMATRIX AC, BLU-U.
Industry payments across PA — which companies pay providers there.
